Skip to main content

Advertisement

Log in

In vivo proton magnetic resonance spectroscopy of breast lesions: an update

  • Review Paper
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In vivo proton magnetic resonance spectroscopy (1H-MRS) has been demonstrated to be successful in the differentiation of benign and malignant breast lesions in a non-invasive manner by detecting increased levels of composite choline (Cho) compounds. Currently there is molecular evidence of increased Cho metabolism in breast cancer cells. In breast malignancies, 1H-MRS achieved a high-overall sensitivity (82%). Most test cases were infiltrating duct carcinoma, but infiltrating lobular, medullary, mucinous and adenoid cystic carcinomas were also positive by 1H-MRS. Large lesional size is a pre-requisite for 1H-MRS testing, and technical problems account for some of the false negative results. Another potential of 1H-MRS is to assess patients’ response to neoadjuvant chemotherapy. In ductal carcinoma in situ, the results of 1H-MRS on the limited number of cases were negative. Most of the assessed benign breast lesions including fibroadenoma, fibrocystic changes, cysts and galactoceles, papilloma, tubular adenoma and phyllodes tumours and were mostly negative by 1H-MRS, with an overall false positive rate was about 8%. Normal breast tissue was almost always negative by 1H-MRS, whereas, lactating breast tissue showed positivity with a slightly different spectrum on further analysis. With the clinical use of stronger field MR scanners and better coils, the sensitivity of 1H-MRS may be further improved. With these improvements, 1H-MRS may potentially be useful in detection of smaller malignant lesions, characterization of malignant lesions into non-invasive or invasive, and as an invaluable tool in disease progression monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13–30

    PubMed  CAS  Google Scholar 

  2. Stavros AT, Thickman D, Rapp CL, et al. (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196:123–134

    PubMed  CAS  Google Scholar 

  3. Buchberger W, Niehoff A, Obrist P, et al. (2000) Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 21:325–336

    Article  PubMed  CAS  Google Scholar 

  4. Degani H, Gusis V, Weinstein D, et al. (1997) Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 3:780–782

    Article  PubMed  CAS  Google Scholar 

  5. Esserman L, Hylton N, Yassa L, et al. (1999) Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17:110–119

    PubMed  CAS  Google Scholar 

  6. Warner E, Plewes DB, Shumak RS, et al. (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524–3531

    PubMed  CAS  Google Scholar 

  7. Madan AK, Nguyen MT, Wakabayashi MN, et al. (2001) Magnification views of mammography decrease biopsy rates. Am Surg 67:687–689

    PubMed  CAS  Google Scholar 

  8. Milz P, Lienemann A, Kessler M, et al. (2001) Evaluation of breast lesions by power Doppler sonography. Eur Radiol 11:547–554

    Article  PubMed  CAS  Google Scholar 

  9. Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy—initial results. Radiology 220:40–46

    PubMed  CAS  Google Scholar 

  10. Yeung DK, Yang WT, Tse GM (2002) Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 225:190–197

    Article  PubMed  Google Scholar 

  11. Cecil KM, Schnall MD, Siegelman ES, et al. (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45–54

    Article  PubMed  CAS  Google Scholar 

  12. Jacobs MA, Barker PB, Bottomley PA, et al. (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75

    Article  PubMed  Google Scholar 

  13. Roebuck JR, Cecil KM, Schnall MD, et al. (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275

    PubMed  CAS  Google Scholar 

  14. Kvistad KA, Bakken IJ, Gribbestad IS, et al. (1999) Characterization of neoplastic and normal human breast tissues with in vivo [1]H MR spectroscopy. J Magn Reson Imaging 10:159–164

    Article  PubMed  CAS  Google Scholar 

  15. Gribbestad IS, Petersen SB, Fjosne HE, et al. (1994) 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 7:181–194

    Article  PubMed  CAS  Google Scholar 

  16. Tse GM, Cheung HS, Pang LM, et al. (2003) Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 181:1267–1272

    PubMed  Google Scholar 

  17. Stanwell P, Gluch L, Clark D, et al. (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 15:1037–1043

    Article  PubMed  Google Scholar 

  18. Kim JK, Park SH, Lee HM, et al. (2003) In vivo 1H-MRS evaluation of malignant and benign breast diseases. Breast 12:179–182

    Article  PubMed  Google Scholar 

  19. Zeisel SH, Da Costa KA, Franklin PD, et al. (1991) Choline, an essential nutrient for humans. FASEB J 5:2093–2098

    PubMed  CAS  Google Scholar 

  20. Zeisel SH (1990) Choline deficiency. J Nutr Biochem 1:332–349

    Article  PubMed  CAS  Google Scholar 

  21. Zeisel SH (1994) Choline modern nutrition in health and disease. 8th edn. Lea & Febiger, Philadelphia, PA

    Google Scholar 

  22. Ting YL, Sherr D, Degani H (1996) Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 16:1381–1388

    PubMed  CAS  Google Scholar 

  23. Katz-Brull R, Margalit R, Bendel P, et al. (1998) Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. MAGMA 6:44–52

    Article  PubMed  CAS  Google Scholar 

  24. Glunde K, Jie C, Bhujwalla ZM (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res 64:4270–4276

    Article  PubMed  CAS  Google Scholar 

  25. Lean C, Doran S, Somorjai RL, et al. (2004) Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 3:551–556

    PubMed  Google Scholar 

  26. Cotran RS, Kumar V, Collins T, et al. (eds) (1999) Robbins pathologic bases of disease. 6th edn. Saunders, Philadelphia, PA, pp. 280–282

  27. Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59:80–84

    PubMed  CAS  Google Scholar 

  28. Jagannathan NR, Kumar M, Seenu V, et al. (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022

    Article  PubMed  CAS  Google Scholar 

  29. Mackinnon WB, Barry PA, Malycha PL, et al. (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 204:661–666

    PubMed  CAS  Google Scholar 

  30. Tan PH, Aw MY, Yip G, et al. (2005) Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol 29:625–632

    Article  PubMed  Google Scholar 

  31. Tse GM, Tan PH, Ma TK, et al. (2005) CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast. J Clin Pathol 58:1185–1188

    Article  PubMed  CAS  Google Scholar 

  32. Tse GM, Tan PH (2005) Recent advances in the pathology of fibroepithelial tumours of the breast. Curr Diagn Pathol 11:426–434

    Article  Google Scholar 

  33. Bolan PJ, Nelson MT, Yee D, et al. (2005) Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res 7:149–152

    Article  PubMed  CAS  Google Scholar 

  34. Guo Y, Cai YQ, Cai ZL, et al. (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16:172–178

    Article  PubMed  Google Scholar 

  35. Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15:154–163

    Article  PubMed  Google Scholar 

  36. Huang W, Fisher PR, Dulaimy K, et al. (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232:585–591

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary M. Tse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tse, G.M., Yeung, D.K.Y., King, A.D. et al. In vivo proton magnetic resonance spectroscopy of breast lesions: an update. Breast Cancer Res Treat 104, 249–255 (2007). https://doi.org/10.1007/s10549-006-9412-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9412-8

Keywords

Navigation